Investors in Aster DM Healthcare are in talks to sell a 30% stake in the company's Indian unit for approximately $300 million, in what could be the latest deal in India's booming healthcare sector. Two sources reported that Aster and its advisors have reached out to KKR & Co. and Max Healthcare Institute, one of India's largest hospital chains, to initiate preliminary discussions about the potential sale of the investors' stake.
Spokespersons for KKR and Olympus declined to comment, while Aster and Remco Moulis & Company did not respond to requests for comment from Reuters.
